Marina Tadolini

Associate Professor of Infectious Diseases from 27/07/2023.

Main fields of interest: epidemiology and clinical management of Tuberculosis (TB), TB/HIV coinfection, MDR-TB and XDR-TB, tuberculosis infection, non-tuberculous mycobacteria, chronic pulmonary infections, ID in migrants and returning travellers.

Senior consultant for World Health Organization for Global TB Programme (Geneva, Switzerland) since 2008.

Degree and Diploma

Degree in Medicine and Surgery in 1997 (Alma Mater Studiorum University of Bologna) with mark 110/110 cum laude.

Specialization Diploma in Infectious Diseases in 2002 (Alma Mater Studiorum University of Bologna) with mark 70/70 cum laude.

Scientific production (last three years)

1. Vanino E, Granozzi B, Akkerman OW, Munoz-Torrico M, Palmieri F, Seaworth B, Tiberi S, Tadolini M, Update of drug-resistant tuberculosis treatment guidelines: A turning point, International Journal of Infectious Diseases (2023), doi:https://doi.org/10.1016/j.ijid.2023.03.013
2. Singh KP, Carvalho ACC, Centis R, D'Ambrosio L, Migliori GB, Mpagama SG, Nguyen BC, Aarnoutse RE, Aleska A, van Altena R, Bhavani PK, Bolhuis M, Borisov S, Boveneind-Vrubleuskaya N, Bruchfeld J, Caminero JA, Carvalho I,Cho JG,Davies-Forsman L, Dedicoat M, Dheda K, Dooley K, Furin J, Garcia JM, Garcia-Prats A, Hesseling AC, Heysell SK, Hu Y, Kim HY, Manga S, Marais B, Margineanu I, Märtson AG, Munoz Torrico M, Nataprawira HM, Nuntes E, Ong CWM; Otto-Knapp R, Palmero DJ, Peloquin CA, Rendon A, Rossato Silva D, Ruslami R, Saktiawati AMI, Santoso P, Schaaf HS, Seaworth B, Simonsson U, Singla R, Skrahina A, Solovic I, Srivasta SK, Stocker SL, Sturkenboom MG, Svensson EM, Tadolini M, Thomas TA, Tiberi S, Trubiano J, Udwadia ZF, Verhage A, Vu DH. Akkerman OW, Alffenaar JVC, Denholm JT, Clinical standards for the management of adverse effects during treatment of tuberculosis. Int J Tuberc Lung Dis 2023. In press
3. Moyo S, Ismail F, Mkhondo N, van der Walt M, Dlamini S, Mthiyane T, Naidoo I, Zuma K, Tadolini M,Law I, Mvusi L. Healthcare seeking patterns for TB symptoms: findings from the first national TB prevalence survey of South Africa, 2017-2019. PLoS ONE 2023. In press.
4. Matji R, Maama L, Roscigno G, Lerotholi M, Agonafir M, Sekibira R, Law I, Tadolini M, AlMossawi HJ, Kak N, Policy and programmatic directions for the Lesotho tuberculosis programme: findings of the national tuberculosis prevalence survey, 2019. PLoS ONE 2023; 18(3): e0273245. https://doi.org/10.1371/journal.pone.0273245
5. Granozzi B, Bisognin F, Tadolini M, Lombardi G, Zangoli E, Salvi D, Dormi A, Dal Monte P. IGRA test for TB in COVID-19: role of corticosteroids. [https://pubmed.ncbi.nlm.nih.gov/36281053/] Int J Tuberc Lung Dis. 2022 Nov 1;26(11):1088-1091. doi: 10.5588/ijtld.22.0283.PMID: 36281053
6. García-García JM, Blanc FX, Buonsenso D, Centis R, Codecasa LR, D'Ambrosio L, Goletti D, Gualano G, Kunst H, Pontali E, Tadolini M, Tiberi S, Ong CWM, Sotgiu G, Migliori GB; Global Tuberculosis Network. COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom. [https://pubmed.ncbi.nlm.nih.gov/36064681/] Arch Bronconeumol. 2022 Nov;58(11):783-785. doi: 10.1016/j.arbres.2022.07.013. Epub 2022 Aug 13.PMID: 36064681
7. Amedeo A, Beci G, Giglia M, Lombardi G, Bisognin F, Chiarucci F, Corsini I, Dal Monte P, Tadolini M. Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings. [https://pubmed.ncbi.nlm.nih.gov/35960758/] PLoS One. 2022 Aug 12;17(8):e0272997. doi: 10.1371/journal.pone.0272997. eCollection 2022.PMID: 35960758
8. Akkerman OW, Duarte R, Tiberi S, Schaaf HS, Lange C, Alffenaar JWC, Denholm J, Carvalho ACC, Bolhuis MS, Borisov S, Bruchfeld J, Cabibbe AM, Caminero JA, Carvalho I, Chakaya J, Centis R, Dalcomo MP, D Ambrosio L, Dedicoat M, Dheda K, Dooley KE, Furin J, García-García JM, van Hest NAH, de Jong BC, Kurhasani X, Märtson AG, Mpagama S, Torrico MM, Nunes E, Ong CWM, Palmero DJ, Ruslami R, Saktiawati AMI, Semuto C, Silva DR, Singla R, Solovic I, Srivastava S, de Steenwinkel JEM, Story A, Sturkenboom MGG, Tadolini M, Udwadia ZF, Verhage AR, Zellweger JP, Migliori GB. Clinical standards for drug-susceptible pulmonary TB. [https://pubmed.ncbi.nlm.nih.gov/35768923/] Int J Tuberc Lung Dis. 2022 Jul 1;26(7):592-604. doi: 10.5588/ijtld.22.0228.PMID: 35768923
9. Alffenaar JWC, Stocker SL, Forsman LD, Garcia-Prats A, Heysell SK, Aarnoutse RE, Akkerman OW, Aleksa A, van Altena R, de Oñata WA, Bhavani PK, Van't Boveneind-Vrubleuskaya N, Carvalho ACC, Centis R, Chakaya JM, Cirillo DM, Cho JG, D Ambrosio L, Dalcolmo MP, Denti P, Dheda K, Fox GJ, Hesseling AC, Kim HY, Köser CU, Marais BJ, Margineanu I, Märtson AG, Torrico MM, Nataprawira HM, Ong CWM, Otto-Knapp R, Peloquin CA, Silva DR, Ruslami R, Santoso P, Savic RM, Singla R, Svensson EM, Skrahina A, van Soolingen D, Srivastava S, Tadolini M, Tiberi S, Thomas TA, Udwadia ZF, Vu DH, Zhang W, Mpagama SG, Schön T, Migliori GB. Clinical standards for the dosing and management of TB drugs. [https://pubmed.ncbi.nlm.nih.gov/35650702/] Int J Tuberc Lung Dis. 2022 Jun 1;26(6):483-499. doi: 10.5588/ijtld.22.0188.PMID: 35650702
10. Moyo S, Ismail F, Van der Walt M, Ismail N, Mkhondo N, Dlamini S, Mthiyane T, Chikovore J, Oladimeji O, Mametja D, Maribe P, Seocharan I, Ximiya P, Law I, Tadolini M, Zuma K, Manda S, Sismanidis C, Pillay Y, Mvusi L. Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey. [https://pubmed.ncbi.nlm.nih.gov/35594897/] Lancet Infect Dis. 2022 Aug;22(8):1172-1180. doi: 10.1016/S1473-3099(22)00149-9. Epub 2022 May 17.PMID: 35594897
11. Granozzi B, Bisognin F, Lombardi G, Dal Monte P, Tadolini M. TB mortality in low-incidence countries: can we reduce it further? [https://pubmed.ncbi.nlm.nih.gov/35505488/] Int J Tuberc Lung Dis. 2022 May 1;26(5):467-469. doi: 10.5588/ijtld.22.0119.PMID: 35505488 No abstract available.
12. Migliori GB, Thong PM, Alffenaar JW, Denholm J, Tadolini M, Alyaquobi F, Al-Abri S, Blanc FX, Buonsenso D, Chakaya J, Cho JG, Codecasa LR, Danila E, Duarte R, Dukpa R, García-García JM, Gualano G, Kurhasani X, Manika K, Mello FCQ, Pahl K, Rendon A, Sotgiu G, Souleymane MB, Thomas TA, Tiberi S, Kunst H, Udwadia ZF, Goletti D, Centis R, D'Ambrosio L, Silva DR. Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study. [https://pubmed.ncbi.nlm.nih.gov/35475873/] J Bras Pneumol. 2022 Apr 20;48(2):e20220087. doi: 10.36416/1806-3756/e20220087. eCollection 2022.PMID: 35475873
13. Tadolini M, Onozaki I National TB prevalence surveys in the COVID-19 era. [https://pubmed.ncbi.nlm.nih.gov/34969421/] .Int J Tuberc Lung Dis. 2022 Jan 1;26(1):4-5. doi: 10.5588/ijtld.21.0585.PMID: 34969421
14. Migliori GB, Thong PM, Alffenaar JW, Denholm J, Tadolini M, Alyaquobi F, Blanc FX, Buonsenso D, Cho JG, Codecasa LR, Danila E, Duarte R, García-García JM, Gualano G, Rendon A, Silva DR, Souleymane MB, Tham SM, Thomas TA, Tiberi S, Udwadia ZF, Goletti D, Centis R, D'Ambrosio L, Sotgiu G, Ong CWM; Global Tuberculosis Network. Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. [https://pubmed.ncbi.nlm.nih.gov/34446465/] Eur Respir J. 2021 Nov 11;58(5):2101786. doi: 10.1183/13993003.01786-2021. Print 2021 Nov.PMID: 34446465
15. Lansang MAD, Alejandria MM, Law I, Juban NR, Amarillo MLE, Sison OT, Cruz JRB, Ang CF, Buensalido JAL, Cañal JPA, Castillo-Carandang NT, Cordero CP, Gaviola DMG, Ladia MAJ, Mantaring JBV 3rd, Mendoza MT, Salamat MSS, Lam HY, Tadolini M, Garfin AMCG; Philippine NTPS 2016 Group. High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey. [https://pubmed.ncbi.nlm.nih.gov/34086746/] PLoS One. 2021 Jun 4;16(6):e0252240. doi: 10.1371/journal.pone.0252240. eCollection 2021.PMID: 34086746
16. Koirala S, Borisov S, Danila E, Mariandyshev A, Shrestha B, Lukhele N, Dalcolmo M, Shakya SR, Miliauskas S, Kuksa L, Manga S, Aleksa A, Denholm JT, Khadka HB, Skrahina A, Diktanas S, Ferrarese M, Bruchfeld J, Koleva A, Piubello A, Koirala GS, Udwadia ZF, Palmero DJ, Munoz-Torrico M, Gc R, Gualano G, Grecu VI, Motta I, Papavasileiou A, Li Y, Hoefsloot W, Kunst H, Mazza-Stalder J, Payen MC, Akkerman OW, Bernal E, Manfrin V, Matteelli A, Mustafa Hamdan H, Nieto Marcos M, Cadiñanos Loidi J, Cebrian Gallardo JJ, Duarte R, Escobar Salinas N, Gomez Rosso R, Laniado-Laborín R, Martínez Robles E, Quirós Fernandez S, Rendon A, Solovic I, Tadolini M, Viggiani P, Belilovski E, Boeree MJ, Cai Q, Davidavičienė E, Forsman LD, De Los Rios J, Drakšienė J, Duga A, Elamin SE, Filippov A, Garcia A, Gaudiesiute I, Gavazova B, Gayoso R, Gruslys V, Jonsson J, Khimova E, Madonsela G, Magis-Escurra C, Marchese V, Matei M, Moschos C, Nakčerienė B, Nicod L, Palmieri F, Pontarelli A, Šmite A, Souleymane MB, Vescovo M, Zablockis R, Zhurkin D, Alffenaar JW, Caminero JA, Codecasa LR, García-García JM, Esposito S, Saderi L, Spanevello A, Visca D, Tiberi S, Pontali E, Centis R, D'Ambrosio L, van den Boom M, Sotgiu G, Migliori GB. Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort. [https://pubmed.ncbi.nlm.nih.gov/33753021/] Pulmonology. 2021 Sep-Oct;27(5):403-412. doi: 10.1016/j.pulmoe.2021.02.006. Epub 2021 Mar 19.PMID: 33753021
17. Migliori GB, Thong PM, Akkerman O, Alffenaar JW, Álvarez-Navascués F, Assao-Neino MM, Bernard PV, Biala JS, Blanc FX, Bogorodskaya EM, Borisov S, Buonsenso D, Calnan M, Castellotti PF, Centis R, Chakaya JM, Cho JG, Codecasa LR, D'Ambrosio L, Denholm J, Enwerem M, Ferrarese M, Galvão T, García-Clemente M, García-García JM, Gualano G, Gullón-Blanco JA, Inwentarz S, Ippolito G, Kunst H, Maryandyshev A, Melazzini M, de Queiroz Mello FC, Muñoz-Torrico M, Njungfiyini PB, Palmero DJ, Palmieri F, Piccioni P, Piubello A, Rendon A, Sabriá J, Saporiti M, Scognamiglio P, Sharma S, Silva DR, Souleymane MB, Spanevello A, Tabernero E, Tadolini M, Tchangou ME, Thornton ABY, Tiberi S, Udwadia ZF, Sotgiu G, Ong CWM, Goletti D .Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. [https://pubmed.ncbi.nlm.nih.gov/32917293/] Emerg Infect Dis. 2020 Nov;26(11):2709-2712. doi: 10.3201/eid2611.203163. Epub 2020 Sep 11.PMID: 32917293
18. Bartoletti M, Giannella M, Scudeller L, Tedeschi S, Rinaldi M, Bussini L, Fornaro G, Pascale R, Pancaldi L, Pasquini Z, Trapani F, Badia L, Campoli C, Tadolini M, Attard L, Puoti M, Merli M, Mussini C, Menozzi M, Meschiari M, Codeluppi M, Barchiesi F, Cristini F, Saracino A, Licci A, Rapuano S, Tonetti T, Gaibani P, Ranieri VM, Viale P; PREDICO study group.Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study). [https://pubmed.ncbi.nlm.nih.gov/32781244/] Clin Microbiol Infect. 2020 Nov;26(11):1545-1553. doi: 10.1016/j.cmi.2020.08.003. Epub 2020 Aug 8.PMID: 32781244
19. Calza L, Bon I, Tadolini M, Borderi M, Colangeli V, Badia L, Verucchi G, Rossini G, Vocale C, Gaibani P, Viale P, Attard L.COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy. [https://pubmed.ncbi.nlm.nih.gov/32748333/] Infection. 2021 Apr;49(2):333-337. doi: 10.1007/s15010-020-01492-7. Epub 2020 Aug 3.PMID: 32748333
20. Tadolini M, García-García JM, Blanc FX, Borisov S, Goletti D, Motta I, Codecasa LR, Tiberi S, Sotgiu G, Migliori GB; GTN TB/COVID group. On tuberculosis and COVID-19 co-infection. [https://pubmed.ncbi.nlm.nih.gov/32586888/] Eur Respir J. 2020 Aug 20;56(2):2002328. doi: 10.1183/13993003.02328-2020. Print 2020 Aug.PMID: 32586888
21. van den Elsen SH, Sturkenboom MG, Akkerman O, Barkane L, Bruchfeld J, Eather G, Heysell SK, Hurevich H, Kuksa L, Kunst H, Kuhlin J, Manika K, Moschos C, Mpagama SG, Muñoz Torrico M, Skrahina A, Sotgiu G, Tadolini M, Tiberi S, Volpato F, van der Werf TS, Wilson MR, Zúñiga J, Touw DJ, Migliori GB, Alffenaar JW. Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study. [https://pubmed.ncbi.nlm.nih.gov/32554740/] BMJ Open. 2020 Jun 16;10(6):e035350. doi: 10.1136/bmjopen-2019-035350.PMID: 32554740
22. Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, Andréjak C, Bachez P, Bart PA, Belilovski E, Cardoso-Landivar J, Centis R, D'Ambrosio L, Luiza De Souza-Galvão M, Dominguez-Castellano A, Dourmane S, Fréchet Jachym M, Froissart A, Giacomet V, Goletti D, Grard S, Gualano G, Izadifar A, Le Du D, Marín Royo M, Mazza-Stalder J, Motta I, Ong CWM, Palmieri F, Rivière F, Rodrigo T, Silva DR, Sánchez-Montalvá A, Saporiti M, Scarpellini P, Schlemmer F, Spanevello A, Sumarokova E, Tabernero E, Tambyah PA, Tiberi S, Torre A, Visca D, Zabaleta Murguiondo M, Sotgiu G, Migliori GB. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. [https://pubmed.ncbi.nlm.nih.gov/32457198/] Eur Respir J. 2020 Jul 9;56(1):2001398. doi: 10.1183/13993003.01398-2020. Print 2020 Jul.PMID: 32457198
23. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. [https://pubmed.ncbi.nlm.nih.gov/32411943/] Motta I, Centis R, D'Ambrosio L, García-García JM, Goletti D, Gualano G, Lipani F, Palmieri F, Sánchez-Montalvá A, Pontali E, Sotgiu G, Spanevello A, Stochino C, Tabernero E, Tadolini M, van den Boom M, Villa S, Visca D, Migliori GB.Pulmonology. 2020 Jul-Aug;26(4):233-240. doi: 10.1016/j.pulmoe.2020.05.002. Epub 2020 May 14.PMID: 32411943
24. Tedeschi S, Giannella M, Bartoletti M, Trapani F, Tadolini M, Borghi C, Viale P.Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019. [https://pubmed.ncbi.nlm.nih.gov/32339215/] Clin Infect Dis. 2020 Jul 28;71(15):899-901. doi: 10.1093/cid/ciaa492.PMID: 32339215
25. Bonsu F, Addo KK, Alebachew Z, Gyapong J, Badu-Peprah A, Gockah R, Hanson-Nortey NN, Law I, Tadolini M, Onozaki I, Sismanidis C, Owusu-Dabo E. National population-based tuberculosis prevalence survey in Ghana, 2013. [https://pubmed.ncbi.nlm.nih.gov/32228763/] Int J Tuberc Lung Dis. 2020 Mar 1;24(3):321-328. doi: 10.5588/ijtld.19.0163.PMID: 32228763
26. Vanino E, Tadolini M, Evangelisti G, Zamparini E, Attard L, Scolz K, Terzi S, Barbanti Brodano G, Girolami M, Pipola V, Gasbarrini A, Viale P. Spinal tuberculosis: proposed spinal infection multidisciplinary management project (SIMP) flow chart revision. [https://pubmed.ncbi.nlm.nih.gov/32096192/] Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1428-1434. doi: 10.26355/eurrev_202002_20201.PMID: 32096192
27. Migliori GB, Tiberi S, Zumla A, Petersen E, Chakaya JM, Wejse C, Muñoz Torrico M, Duarte R, Alffenaar JW, Schaaf HS, Marais BJ, Cirillo DM, Alagna R, Rendon A, Pontali E, Piubello A, Figueroa J, Ferlazzo G, García-Basteiro A, Centis R, Visca D, D'Ambrosio L, Sotgiu G; members of the Global Tuberculosis Network MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. [https://pubmed.ncbi.nlm.nih.gov/32032752/] .Int J Infect Dis. 2020 Mar;92S:S15-S25. doi: 10.1016/j.ijid.2020.01.042. Epub 2020 Feb 4.PMID: 32032752 Review.

Partecipazioni in qualità di relatore e coordinatore scientifico di simposi a numerosi congressi nazionali ed internazionali.

Boards/Expert panel

Since 2009: Childhood TB Subgroup, DOTS Expansion Working Group.

Since 2010: WHO Global Task Force for TB Impact Measurement

2013-2018: Medical Coordinator of ERS/WHO TB Consilium

Since 2013: member of Stop TB Italia ODV.

Since 2013: member of International Union Against Tuberculosis and Lung Diseases

Since 2018: Chair of Global TB Consilium Technical Committee

Associate Editor of International Journal of Tuberculosis and Lung Diseases since 2022

Editorial Board Member of European Respiratory Journal since 2017

Referee of peer reviewed journals: European Respiratory Journal, BMC Public Health, BMC Infectious Diseases, Medicine, International Journal of Tuberculosis and Lung Diseases, Lancet ID